N

NextCell Pharma AB
STO:NXTCL

Watchlist Manager
NextCell Pharma AB
STO:NXTCL
Watchlist
Price: 1.448 SEK -12.14% Market Closed
Market Cap: 161.3m SEK

Wall Street
Price Targets

NXTCL Price Targets Summary
NextCell Pharma AB

Wall Street analysts forecast NXTCL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.535 SEK and a high forecast of 3.675 SEK.

Lowest
Price Target
3.535 SEK
144% Upside
Average
Price Target
3.57 SEK
147% Upside
Highest
Price Target
3.675 SEK
154% Upside
NextCell Pharma AB Competitors:
Price Targets
VAC
Pierre et Vacances SA
27% Upside
8841
TOC Co Ltd
26% Upside
CSGP
CoStar Group Inc
30% Upside
RYI
Ryerson Holding Corp
-18% Downside

Revenue
Forecast

34% / Year
Past Growth
429% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
34% / Year
Past Growth
429% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 9 years the compound annual growth rate for NextCell Pharma AB's revenue is 34%. The projected CAGR for the next 2 years is 429%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NXTCL's stock price target?
Price Target
3.57 SEK

According to Wall Street analysts, the average 1-year price target for NXTCL is 3.57 SEK with a low forecast of 3.535 SEK and a high forecast of 3.675 SEK.

What is NextCell Pharma AB's Revenue forecast?
Projected CAGR
429%

For the last 9 years the compound annual growth rate for NextCell Pharma AB's revenue is 34%. The projected CAGR for the next 2 years is 429%.

Back to Top